-
Originally Posted by Swooping
This is just another collaboration that Tsuji has done. He is still moving forward with his in vitro method revolving around mesenchymal-epithelial interactions for hair follicle regeneration. A press release will be brought out soon about that.
Going to go on a limb and say that you don't have much hope for the Turkey or Brotzu topicals...?
-
Senior Member
Collaborative Research Agreement with Exclusive Option to Produce Universal Donor iPS
April 6, 2016 (Seattle)-Universal Cells Inc. (Seattle WA, USA) and HEALIOS K.K. (“Healios”) (Tokyo, Japan) have entered into a collaborative research and exclusive option agreement to create therapeutic off-the-shelf iPSCs. The partnership will focus on the production of Universal Donor iPSCs by editing the genes required for antigen presentation.
“Partnering with the world’s leading company in iPSC therapeutics, and the leading nation for accelerated regulatory approval for regenerative medicine products is a significant step towards bringing universal donor cells into the clinic”, commented Dr. Mitchell, CEO of Universal Cells.
Universal Cells’ technology is based on discoveries by Dr. David Russell, the co-founder and Chief Scientific Officer of Universal Cells, and a world-renowned leader in gene editing. Universal Cells has licensed patents on recombinant adeno-associated viral (rAAV)-mediated gene editing, and HLA engineering.
With Universal Cells’ proprietary technology, Healios intends to develop next-generation allogeneic iPSCs that are compatible with everyone. Although autologous iPSC manufacturing is feasible, an off-the-shelf cell line has the potential to revolutionize the field of cell therapy by enabling the scalable production of safe, effective, and predictable treatments.
“iPSC regenerative medicine is our core business. When iPSC regenerative medicine with less risk of transplant rejection can be developed from iPS cells regardless of HLA type, safety of treatment is improved, and treatments for a variety of diseases can be developed. This technology enhances clinical application of iPS cell technology,” commented Dr. Hardy Kagimoto, President, representative director and CEO of Healios.
During the option period, Universal Cells will engineer Healios’ clinical-grade iPSCs. The exclusive option is for the treatment of dry/wet AMD, and for use with Healios’ proprietary Organ Bud technology in liver and kidney clinical fields.
Source: http://universalcells.com/new/healios
-
What? Is that actually saying stem cells don't have to come from your own body and they want to mass-produce them?
-
Sounds cool to me.
I don't believe in a god but let's pray that no right wing anti science weirdo God botherers get into power in the next USA elections.
Otherwise it's goodbye stem cell research funding until the level level headed science focused Govt gets into power.
Although if Drumph (Trump) gets to be president maybe he will expedite a solution
Similar Threads
-
By Tenma in forum Cutting Edge / Future Treatments
Replies: 24
Last Post: 01-25-2015, 10:09 AM
-
By Artha in forum Cutting Edge / Future Treatments
Replies: 2
Last Post: 04-18-2014, 12:05 PM
-
By DepressedByHairLoss in forum Cutting Edge / Future Treatments
Replies: 1
Last Post: 05-20-2011, 07:09 PM
-
By clee984 in forum Cutting Edge / Future Treatments
Replies: 4
Last Post: 08-25-2010, 11:31 PM
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
Forum Rules
|
» IAHRS
» The Bald Truth
» americanhairloss.org
|
Bookmarks